Announcements Trials

Browse Landscape

Phase

Status

Unknown 8 Not yet recruiting 3 Completed 3 Terminated 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 29 Plasma cell 1 Lymphoid 1 Gynecologic 1 Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 87 Specimen Handling 76 pembrolizumab 74 enzalutamide 57 Radiosurgery 57 Radiotherapy 51 Docetaxel 50 Androgen Antagonists 48 Gemcitabine 43 Nivolumab 40 darolutamide 39 Prednisone 35 Abiraterone Acetate 33 enfortumab vedotin 32 Biopsy 31 Cisplatin 30 Carboplatin 29 apalutamide 28 Standard of Care 28 cabozantinib 27 Pluvicto 27 abiraterone 26 Blood Specimen Collection 25 Radiation 23 Leuprolide 23 Ipilimumab 23 X-Rays 18 relugolix 17 Triptorelin Pamoate 17 Surveys and Questionnaires 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Epirubicin × Genitourinary × Clear all

NCT05024734 2025-03-11

GAIN INST

Hospital Centre Biel/Bienne

Phase 2 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡